Educational

Veterans have played an unusually visible role in the modern psychedelic-therapy conversation, particularly through advocacy and research surrounding MDMA-assisted therapy for PTSD. That focus makes sense, but veteran mental health is much broader than post-traumatic stress disorder alone. Depression, anxiety, grief, substance use, chronic pain, sleep problems, relationship difficulties, and what clinicians sometimes describe as […]

Obsessive-compulsive disorder can be persistent, disabling, and difficult to treat. Established approaches such as Exposure and Response Prevention therapy and certain psychiatric medications help many people, but some continue to experience significant symptoms despite appropriate care. That treatment gap has encouraged researchers to explore new approaches, including psilocybin-assisted therapy. Early findings have generated interest, but […]

Most public discussion about psychedelic therapy focuses on the treatment session itself. Researchers and clinicians often place just as much emphasis on what happens before anyone receives a psychedelic substance. Screening is one of the most important parts of responsible psychedelic-assisted treatment. It helps clinicians understand a person’s medical history, psychiatric history, medications, treatment goals, […]

Ketamine has become increasingly visible in mental health care because of its role in treating certain forms of severe or treatment-resistant depression. As its use has expanded, patients have understandably begun asking whether ketamine may also help anxiety. Researchers have explored ketamine across several anxiety-related conditions, and some findings are encouraging. The evidence is not […]

MDMA has received most of the attention surrounding psychedelic-assisted therapy for post-traumatic stress disorder, but it is not the only psychedelic researchers are interested in. Psilocybin is being investigated across a growing range of psychiatric conditions, raising an obvious question: could it eventually have a role in treating PTSD? At this point, the science is […]

Grief is a normal response to loss, and most people who are grieving do not have a psychiatric disorder that requires treatment. At the same time, grief can become prolonged, disabling, or intertwined with depression, trauma, anxiety, guilt, or difficulty reengaging with everyday life. As psychedelic research has expanded, scientists have started asking whether treatments […]

Ketamine is most commonly associated with treatment-resistant depression, while MDMA has dominated the psychedelic-therapy conversation surrounding post-traumatic stress disorder. But researchers have also been investigating an important question: Could ketamine help some people with PTSD? The answer is more complicated than a simple yes or no. Research has produced encouraging findings, including evidence that ketamine […]

Anxiety disorders are among the most common mental health conditions, but they are also remarkably diverse. Generalized anxiety, panic, social anxiety, trauma-related symptoms, and anxiety associated with serious illness can look very different from one another and may respond differently to treatment. As interest in psychedelic-assisted therapy has grown, researchers have begun examining whether psilocybin […]

Interest in psychedelic-assisted therapy has grown rapidly over the past decade, fueled by research into treatments such as psilocybin, MDMA, and ketamine. News headlines often highlight promising study results, leading many people to wonder whether these therapies are already proven to work. The reality is more nuanced. Clinical trials are the reason we know as […]

Interest in psychedelic-assisted therapy has grown rapidly as researchers continue studying treatments such as psilocybin, MDMA, and ketamine for a variety of mental health conditions. However, one of the most important things to understand is that these therapies are not appropriate for everyone. Determining whether someone may be a good candidate requires a comprehensive medical […]